CF-301-102 Study
Clinical Trial Grant
Awarded By
ContraFect Corporation
Start Date
October 14, 2016
End Date
April 30, 2020
Awarded By
ContraFect Corporation
Start Date
October 14, 2016
End Date
April 30, 2020